Avenue Therapeutics Inc

NASDAQ:ATXI  
2.41
-0.31 (-11.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Avenue Therapeutics Inc Stock, NASDAQ:ATXI

1140 Avenue of the Americas, 9th floor, New York, New York 10036
United States of America
Phone: +1.781.652.4500
Number of Employees: 4

Description

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.